Pharmacokinetics and Tolerability of LC28-0126, a Novel Necrosis Inhibitor, After Multiple Ascending Doses: A Phase I Randomized, Double-blind, Placebo-controlled Study in Healthy Male Subjects.
Clin Ther
; 42(10): 1946-1954.e2, 2020 10.
Article
in En
| MEDLINE
| ID: mdl-32980184
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hydrocarbons, Halogenated
/
Ketones
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adult
/
Humans
/
Male
Language:
En
Journal:
Clin Ther
Year:
2020
Document type:
Article